About
For Research Partners
News & Events
About Neurostimulation
For Providers
Clinical Evidence
For Patients
Back to News & Events
Dallas-Based Spark Biomedical Gets FDA Clearance for its Drug‑Free Solution to Opioid Withdrawal
February 18, 2021
Media Coverage